SPONSOR
N.N. Petrov National Medical Research Center of Oncology
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: RAS MutationRas (Kras or Nras) Gene MutationColorectal Cancer RecurrentPancreas CancerLung CancerMelanomaRefractory CancerSoft Tissue Sarcoma Adult
NCT06229340 Phase 2
Recruiting
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
RAS Mutation
NCT04330456
Recruiting
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Soft Tissue Sarcoma Adult